跳至主要内容
临床试验/IRCT2016040525160N3
IRCT2016040525160N3已完成未知

Effect of Buprenorphine and Bupropion in the reduction of cannabis craving

Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
Male

入选标准

  • Age between 18 to 50; They are free to participate in the study, patient's major substance use be cannabis
  • Exclusion criteria: Patients unwilling to participate at beginning or during the study, use of another substance except cannabis as of the main substance.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shiraz University of Medical Sciences

相似试验